eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Get Medicines Compendium UK app here

Pfizer Limited

Ramsgate Road, Sandwich, Kent, CT13 9NJ
Telephone: +44 (0)1304 616 161
Fax: +44 (0)1304 656 221

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Patient Information Leaflet last updated on the eMC: 17/04/2012
PIL Pro-Epanutin Concentrate for Infusion / Solution for Injection

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 17/04/2012 and displayed until Current
Reasons for adding or updating:
  • Change to side-effects
Updated on 11/07/2011 and displayed until 17/04/2012
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 24/09/2010 and displayed until 11/07/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change to side-effects
  • Change to drug interactions
Updated on 01/04/2010 and displayed until 24/09/2010
Reasons for adding or updating:
  • Change of trade or generic name
  • Change to date of revision
  • Correction of spelling/typing errors
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to drug interactions
Updated on 08/02/2010 and displayed until 01/04/2010
Reasons for adding or updating:
  • Change to appearance of the medicine
  • Change to Further Information section
  • Change to date of revision
  • Correction of spelling/typing errors
  • Change to warnings or special precautions for use
Updated on 29/01/2009 and displayed until 08/02/2010
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 20/01/2009 and displayed until 29/01/2009
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change due to user-testing of patient information
Updated on 23/01/2006 and displayed until 20/01/2009
Reasons for adding or updating:
  • Change of licence holder
Updated on 25/01/2005 and displayed until 23/01/2006
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC

Active Ingredients/Generics

 
   fosphenytoin sodium